Stay updated with breaking news from Remunity Pump. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Brandes Investment Partners LP increased its position in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 4.7% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 15,209 shares of the biotechnology company’s stock after buying an additional 689 shares during the quarter. Brandes […]
Brandes Investment Partners LP lifted its position in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 4.7% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 15,209 shares of the biotechnology company’s stock after buying an additional 689 shares […]
StockNews.com cut shares of United Therapeutics (NASDAQ:UTHR – Free Report) from a strong-buy rating to a buy rating in a report published on Wednesday. Other equities analysts have also issued reports about the stock. JPMorgan Chase & Co. boosted their target price on shares of United Therapeutics from $290.00 to $294.00 and gave the company […]
The Goldman Sachs Group upgraded shares of United Therapeutics (NASDAQ:UTHR – Free Report) from a sell rating to a neutral rating in a research report sent to investors on Monday morning, MarketBeat reports. The firm currently has $215.00 target price on the biotechnology company’s stock, up from their prior target price of $213.00. UTHR has […]
The Goldman Sachs Group upgraded shares of United Therapeutics (NASDAQ:UTHR – Free Report) from a sell rating to a neutral rating in a research report released on Monday, MarketBeat reports. The Goldman Sachs Group currently has $215.00 price target on the biotechnology company’s stock, up from their prior price target of $213.00. Other equities analysts […]